Diamante Overview

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2.71M

  • Investors
  • 11

Diamante General Information

Description

Developer of plant-based nanotechnologies intended for autoimmune disease diagnosis and therapy. The company exploits plants as bioreactors for the production of modified plant virus nanoparticles, enabling scientists to develop new tools for the therapy of autoimmune diseases, based on the re-induction of autoimmune diseases.

Contact Information

Website
www.diamante.tech
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Viale del Lavoro, 33
  • 37135 Verona(Strada le Grazie)
  • Italy
+39 045
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Nanotechnology, HealthTech, Life Sciences
Corporate Office
  • Viale del Lavoro, 33
  • 37135 Verona(Strada le Grazie)
  • Italy
+39 045

Diamante Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Diamante Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Grant 13-Mar-2024 $2.71M Completed Pre-Clinical Trials
11. Accelerator/Incubator Completed Pre-Clinical Trials
10. Accelerator/Incubator Completed Pre-Clinical Trials
9. Seed Round 17-Jan-2023 Completed Pre-Clinical Trials
8. Angel (individual) 05-Aug-2022 Completed Startup
7. Accelerator/Incubator 01-Jan-2022 Completed Startup
6. Accelerator/Incubator 01-Jan-2020 Completed Startup
5. Grant 01-Nov-2017 Completed Startup
4. Accelerator/Incubator 01-Jan-2016 Completed Startup
3. Accelerator/Incubator 01-Jan-2016 Completed Startup
To view Diamante’s complete valuation and funding history, request access »

Diamante Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
To view Diamante’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Diamante Patents

  • 8

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Diamante Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4753730-A1 Composition and methods for treating multiple sclerosis Pending 01-Aug-2023
WO-2025027015-A1 Composition and methods for treating multiple sclerosis Inactive 01-Aug-2023
WO-2025027013-A1 Composition and methods for treating system lupus erythematosus Inactive 01-Aug-2023
US-12527849-B2 Apparatus for determining administration form of a composition of an engineered virus-based nanoparticle for a treatment of an autoimmune condition Active 15-Dec-2021
US-20240148844-A1 Apparatus for determining administration form of a composition of an engineered virus-based nanoparticle for a treatment of an autoimmune condition Active 15-Dec-2021 A61K39/0008
To view Diamante’s complete patent history, request access »

Diamante Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Diamante Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Accelerator/Incubator
Arieli Group Venture Capital Minority
G-Factor Accelerator/Incubator Minority
Premiaweb Venture Capital Minority
Angels4Women Angel Group Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Diamante FAQs

  • Where is Diamante headquartered?

    Diamante is headquartered in Verona, Italy.

  • What is the size of Diamante?

    Diamante has 6 total employees.

  • What industry is Diamante in?

    Diamante’s primary industry is Drug Discovery.

  • Is Diamante a private or public company?

    Diamante is a Private company.

  • What is Diamante’s current revenue?

    The current revenue for Diamante is .

  • How much funding has Diamante raised over time?

    Diamante has raised $990K.

  • Who are Diamante’s investors?

    European Innovation Council, Arieli Group, G-Factor, Premiaweb, and Angels4Women are 5 of 11 investors who have invested in Diamante.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process